Insitro Company
At insitro, we are building a different kind of drug company to bring better drugs faster to the patients who can benefit most. Through the power of machine learning (ML) and data at scale, we decode the complexities of biology to unlock transformative new medicines.
Investors
Connections from
Last Funding Type:
Series C
Funding Status:
Late Stage Venture
Headquarters:
South San Francisco, California, United States
Founded Date:
2018-01-01
Last Funding Date:
2021-03-15
Total Funding:
743000000
Employee Number:
101-250
Investors Number:
20
Industry:
Medical BioTech